Navigation Links
DURATION-6 Top-Line Study Results Announced
Date:3/3/2011

week) (n=461) or Victoza (forced titration to 1.8 mg, once per day) (n=451). The primary endpoint was reduction in A1C, while secondary endpoints included change in body weight along with other parameters of glucose control, cardiovascular health and safety and tolerability.

About Diabetes

Diabetes affects nearly 26 million people in the U.S. and an estimated 285 million adults worldwide.(i, ii)  Approximately 90-95 percent of those affected have type 2 diabetes. Diabetes costs approximately $174 billion per year in direct and indirect medical expenses.(iii)

According to the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey, approximately 60 percent of people with diabetes do not achieve their target blood sugar levels with their current treatment regimen.(iv) In addition, 85 percent of type 2 diabetes patients are overweight and 55 percent are considered obese.(v) Data indicate that weight loss (even a modest amount) supports patients in their efforts to achieve and sustain glycemic control.(vi, vii)

About BYETTA® (exenatide) injection

BYETTA was the first GLP-1 receptor agonist to be approved by the FDA for the treatment of type 2 diabetes. BYETTA exhibits many of the same effects as the human incretin hormone GLP-1. GLP-1 improves blood sugar after food intake through multiple effects that work in concert on the stomach, liver, pancreas and brain.

BYETTA is an injectable prescription medicine that may improve blood sugar (glucose) control in adults with type 2 diabetes mellitus, when used with a diet and exercise program. BYETTA is not insulin and should not be taken instead of insulin. BYETTA is not currently recommended to be taken with insulin. BYETTA is not for people with type 1 diabetes or people with diabetic ketoacidosis. BYETTA has not been studied in people who have pancreatitis.

BYETTA provides sustained A1C control and low incidence
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.; Eli Lilly and Company; Alkermes, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. CuraGen Announces Top-Line Phase II Results on Velafermin
2. Top-Line Efficacy Data Presented from Phase 2 Trial of Alemtuzumab in Multiple Sclerosis
3. Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
4. Schering-Plough Reports Top-Line Results of the IDEAL Study
5. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
6. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
7. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
8. Inspires Phase 3 CF Trial, Using PARIs Nebulizer & Compressor, Shows Positive Top-Line Results
9. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
10. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
11. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... July 1, 2015 Rock Creek Pharmaceuticals, Inc., ... on chronic inflammatory disease and neurologic disorders, announced today ... with anatabine citrate, the Company,s lead compound. Results from ... anatabine citrate can significantly inhibit the activation of inflammatory ... is developing this compound in a Phase 1 clinical ...
(Date:7/1/2015)... SAN FRANCISCO , July 1, 2015 ... a new study Stationary Oxygen Concentrators Market ... markets are poised to achieve continuing growth as the ... develop COPD and other respiratory conditions where oxygen is ... a dramatic manner. Portable devices have become affordable and ...
(Date:7/1/2015)... DIEGO , July 1, 2015 OncoSec Medical ... intratumoral cancer immunotherapies, today announced that CEO and President ... celebration of the Company,s listing to The Nasdaq Stock Market ... Nasdaq MarketSite in New York City . ... employees, investors, and stakeholders, we are honored to open the ...
Breaking Medicine Technology:Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 2Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 3Rock Creek Pharmaceuticals Reports Human Proof of Principle Study of Lead Compound Demonstrating Inhibition of Inflammatory Markers In White Blood Cells 4Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell 2OncoSec Medical to Ring The Nasdaq Stock Market Opening Bell 3
... releases of Elekta,s XiO® treatment planning system and Focal ... and deliver radiation therapy plans more efficiently. ... Therapy (IMRT) segmentation algorithm, fluence map smoothing and DICOM ... for contouring, enabling clinicians to contour anatomy faster and ...
... the vaccines division of Sanofi (EURONEXT: SAN and NYSE: ... 2011-2012 Fluzone® Influenza Virus Vaccine in the U.S. This shipment ... influenza vaccine the company plans to deliver to the U.S. ... producer of influenza vaccine in the U.S., supplying more than ...
Cached Medicine Technology:Latest Releases of Elekta's XiO Planning and Focal Contouring Systems Designed to Increase Efficiency in Planning Therapy for Patients with Cancer 2Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 2Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 3Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 4Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 5Sanofi Pasteur Starts Shipping Influenza Vaccine for the 2011-2012 Season 6
(Date:7/1/2015)... ... July 01, 2015 , ... Ormco Corporation, ... that its fifth annual Smile for a Lifetime Foundation (S4L) fundraising event held ... In addition to supporting S4L in its mission to provide free quality orthodontic ...
(Date:7/1/2015)... ... ... Renowned rhinoplasty surgeon and Symposium Chairman, Dr. Rod J. Rohrich ... for March 6th - 8th, the 2016 meeting will be held at the Westin ... of nasal surgery through the most modern advancements and updates in rhinoplasty and ...
(Date:7/1/2015)... ... July 01, 2015 , ... The 28th annual Charity Horse ... Saturday, July 11, 2015, at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. ... rides, a petting zoo, an Elvis impersonator, a silent auction and concessions. , Horses ...
(Date:7/1/2015)... ... July 01, 2015 , ... Trevor L. Williams, DMD holds a Bachelor ... at USF earning a Master’s degree in Microbiology. He graduated from the University of ... Dental Association, the Florida Dental Association and the Academy of General Dentistry. Dr. Williams ...
(Date:7/1/2015)... ... July 01, 2015 , ... Boar’s Head Brand®, one of ... for Independence Day celebrations with new takes on classic dishes. From chicken salad ... for any summertime get together. , “Celebrating with family, friends, and great food ...
Breaking Medicine News(10 mins):Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Trevor L. Williams, D.M.D. Joins Enlow & Vance Dental Partners in Tampa, Florida 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 2Health News:Boar’s Head Helps Craft a Delicious Independence Day 3
... always a benefit, study of seniors suggests , THURSDAY, Jan. ... will kill you, a new Australian study finds that overweight ... die over a 10-year period than their normal-weight peers. , ... the American Geriatrics Society , conflicts with research that suggests ...
... , Crohn,s & Colitis Foundation of America Received ... During the 2009 Season , NEW YORK , ... (CCFA) today announced the culmination of the second consecutive year of ... David Garrard , quarterback of the Jacksonville Jaguars ® (1) and ...
... Dr. Diana Kirschner,s ... Men Play: 16 Men,s Deadly Dating Patterns that will help women either successfully DATE ... advice for single mothers, women over 45, successful professionals and African-Americans. , ... (PRWEB) January 28, 2010 -- A new year, ...
... ... has licensed Sunquest Collection Manager™ automated specimen collection software , ... (PRWEB) January 28, 2010 ... outreach solutions, announced that Valley Medical Center, in Renton, Washington, has licensed ...
... ... for the parents of disabled or special needs children in and around the Houston, TX area. ... attending one of our workshops. , ... (PRWEB) January 28, 2010 -- Bella’s House Community News is dedicated to supporting ...
... have identified several cytokines, cytokine-related factors, and chemokines that ... These findings confirm those of earlier studies which ... predicted and disease progression may be prevented. Complete findings ... of Arthritis & Rheumatism , a journal of ...
Cached Medicine News:Health News:Over 70 and Overweight May Add Years to Life 2Health News:Pro Quarterback David Garrard Raises $180,000 for Crohn's Disease Education and Research During 2009 Football Season 2Health News:Pro Quarterback David Garrard Raises $180,000 for Crohn's Disease Education and Research During 2009 Football Season 3Health News:Pro Quarterback David Garrard Raises $180,000 for Crohn's Disease Education and Research During 2009 Football Season 4Health News:New Paperback Dating Advice Book, Love in 90 Days, Reveals 16 Men's Dead-End Dating Patterns and What To Do About Them 2Health News:New Paperback Dating Advice Book, Love in 90 Days, Reveals 16 Men's Dead-End Dating Patterns and What To Do About Them 3Health News:Sunquest Information Systems Enters Into Business Relationship with Valley Medical Center of Washington 2Health News:Announcing the Launch of a New Workshop and Forum for Parents of Disabled Children 2Health News:Announcing the Launch of a New Workshop and Forum for Parents of Disabled Children 3Health News:Blood test can predict rheumatoid arthritis before symptoms arise 2
Industry leader in the design and manufacturing of GP Lenses. Abba holds the CLMA seal of excellence award....
... data collection and management ... multiple store environment. Home ... office with the stores ... and inventory reporting, recalls ...
This computerized retail software is aimed for opticians/optometrists, optical chains/1 hr superstores, optical HMOs, and ophthalmology groups....
... SDS Octoplus Ordering/Dispensing has gained recognition as ... lens ordering system. It enables opticians to ... using SDS electronic communications technology. When used ... or 3D frame tracers, lens shapes are ...
Medicine Products: